IQVIA Holdings Inc. posted second-quarter 2025 profit and revenue above Wall Street expectations, with total revenue reaching $4,017 million, an increase of 5.3% from the prior year. This strong performance was driven by resilient demand for its healthcare data and analytics services.
The Technology & Analytics Solutions (TAS) segment continued its robust growth, contributing significantly to the revenue beat. The company's adjusted diluted EPS for the quarter also surpassed estimates, demonstrating strong profitability.
IQVIA updated its full-year 2025 revenue guidance to between $16,100 million and $16,300 million. This adjustment reflects the company's current performance and outlook for the remainder of the year.
During the quarter, IQVIA completed a significant share buyback, repurchasing 3,985,000 shares of its common stock. This action underscores the company's commitment to returning capital to shareholders and signals confidence in its valuation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.